Promotor Methylation | List of Frontiers open access articles

Original Research

Published on 12 May 2020

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

in Neuro-Oncology and Neurosurgical Oncology

Fatih Incekara
Sebastian R. van der Voort
Hendrikus J. Dubbink
Peggy N. Atmodimedjo
Rishi Nandoe Tewarie
Geert Lycklama
Arnaud J. P. E. Vincent
Johan M. Kros
Stefan Klein
Martin van den Bent

Frontiers in Oncology

doi 10.3389/fonc.2020.00596

5,755 views
13 citations

Original Research

Published on 25 Feb 2020

Histogram Analysis of Diffusion Weighted Imaging in Low-Grade Gliomas: in vivo Characterization of Tumor Architecture and Corresponding Neuropathology

in Cancer Imaging and Image-directed Interventions

Georg Alexander Gihr
Diana Horvath-Rizea
Elena Hekeler
Oliver Ganslandt
Hans Henkes
Karl-Titus Hoffmann
Cordula Scherlach
Stefan Schob

Frontiers in Oncology

doi 10.3389/fonc.2020.00206

8,542 views
28 citations

Original Research

Published on 21 Nov 2018

Age-Related Changes on CD40 Promotor Methylation and Immune Gene Expressions in Thymus of Chicken

in Comparative Immunology

Yulong Li
Xinyu Lei
Hong Lu
Wei Guo
Shengru Wu
Zhenchen Yin
Qingzhu Sun
Xiaojun Yang

Frontiers in Immunology

doi 10.3389/fimmu.2018.02731

6,623 views
7 citations

Original Research

Published on 29 Nov 2018

Association Analysis of NLRP3 Inflammation-Related Gene Promotor Methylation as Well as Mediating Effects on T2DM and Vascular Complications in a Southern Han Chinese Population

in Clinical Diabetes

Zixing Zhou
Lijun Wang
Zihao Wen
Shaoling Zheng
Xiaohong Ye
Dandan Liu
Jing Wu
Xiaoqian Zou
Yumei Liu
Yao Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2018.00709

4,717 views
12 citations

Original Research

Published on 28 Sep 2022

PCDH20 inhibits esophageal squamous cell carcinoma proliferation and migration by suppression of the mitogen-activated protein kinase 9/AKT/β-catenin pathway

in Molecular and Cellular Oncology

Yijiao Ning
Chaoqun Deng
Chunhong Li
Weiyan Peng
Chun Yan
Jing Ran
Weihong Chen
Yujia Liu
Jiuyi Xia
Lin Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.937716

3,759 views
7 citations

Original Research

Published on 08 Mar 2022

Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease

in Neuro-Oncology and Neurosurgical Oncology

Jodi Goldman
Akifumi Hagiwara
Jingwen Yao
Catalina Raymond
Christian Ong
Rojin Bakhti
Elizabeth Kwon
Maguy Farhat
Carlo Torres
Lily G. Erickson

Frontiers in Oncology

doi 10.3389/fonc.2022.849993

3,660 views
4 citations

Original Research

Published on 09 Sep 2022

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma

in Cancer Genetics and Oncogenomics

Lei Zhou
Guojie Chen
Tao Liu
Xinyuan Liu
Chengxiao Yang
Jianxin Jiang

Frontiers in Genetics

doi 10.3389/fgene.2022.965805

5,037 views
4 citations

Articles

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

Histogram Analysis of Diffusion Weighted Imaging in Low-Grade Gliomas: in vivo Characterization of Tumor Architecture and Corresponding Neuropathology

Age-Related Changes on CD40 Promotor Methylation and Immune Gene Expressions in Thymus of Chicken

Association Analysis of NLRP3 Inflammation-Related Gene Promotor Methylation as Well as Mediating Effects on T2DM and Vascular Complications in a Southern Han Chinese Population

PCDH20 inhibits esophageal squamous cell carcinoma proliferation and migration by suppression of the mitogen-activated protein kinase 9/AKT/β-catenin pathway

Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma